Does DAROLUTAMIDE Cause Metastases to bone? 81 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Metastases to bone have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 2.5% of all adverse event reports for DAROLUTAMIDE.
81
Reports of Metastases to bone with DAROLUTAMIDE
2.5%
of all DAROLUTAMIDE reports
2
Deaths
14
Hospitalizations
How Dangerous Is Metastases to bone From DAROLUTAMIDE?
Of the 81 reports, 2 (2.5%) resulted in death, 14 (17.3%) required hospitalization.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAROLUTAMIDE. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which DAROLUTAMIDE Alternatives Have Lower Metastases to bone Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR